Amgen Inc share price logo

Amgen Inc

NASDAQ: AMGN

Large Cap

$333.50

-2.79

(-0.83%)

Live

as on

Amgen Inc Stock Performance

as on May 14, 2026 at 4:08 am IST

  • Day's Low

    Day's High

    $330.06
    $338.00
    downward going graph

    1.03%

    Downside

    1.35%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $261.43
    $391.29
    downward going graph

    21.61%

    Downside

    17.33%

    Upside

    downward going graph

Amgen Inc share price movements today

Previous Close
$336.29
Open
$332.32
Volume
592.3K
Day's Low - High
$330.06 - $338.00
52 Week Low - High
$261.43 - $391.29

Amgen Inc Historical Returns

1 Month Return
-3.87 %
3 Month Return
-8.91 %
1 Year Return
+ 24.34 %
3 Year Return
+ 44.36 %
5 Year Return
+ 33.41 %

Amgen Inc Stock Fundamentals & Key Indicators

Check Amgen Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$178.0B

EPS (TTM)

22.4229

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.04%

PE Ratio (TTM)

22.94

Industry PE ratio

20.55666666666667

PEG Ratio

2.1923

EBITDA

16.9B

Revenue (TTM)

37.2B

Profit Margin

20.96%

Return On Equity TTM

101.32%

Amgen Inc Stock Valuation

Track how Amgen Inc P/E has moved over time to understand its valuation trends.

Amgen Inc in the last 5 years

  • Overview

  • Trends

Lowest (12.34x)

December 31, 2021

Industry (20.56x)

May 13, 2026

Today (22.94x)

May 13, 2026

Highest (17.02x)

September 30, 2024

LowHigh

Today’s Price to Earnings Ratio: 22.94x

Amgen Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Amgen Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$178.0B33.41%22.9420.96%
BUY$282.0B235.22%27.3917.19%
BUY$862.3B407.78%34.3334.99%
BUY$358.3B78.27%99.45.79%
BUY$533.0B31.95%25.6321.83%

Stock Returns calculator for Amgen Inc Stock including INR - Dollar returns

The Amgen Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Amgen Inc investment value today

Current value as on today

₹1,38,396

Returns

₹38,396

(+38.4%)

Returns from Amgen Inc Stock

₹23,313 (+23.31%)

Dollar Impact

₹15,083 (+15.08%)

Analyst Recommendation on Amgen Inc Stock

Based on 37 analysts

BUY

56.76%

Buy

35.14%

Hold

8.11%

Sell

Based on 37 analysts, 56.76% of analysts recommend a 'BUY' rating for Amgen Inc. Average target price of $353.07

Amgen Inc Share Price Target

Get share price movements and forecasts by analysts on Amgen Inc.

What analysts predicted

5.54%UPSIDE

Target Price

$353.07

Current Price

$333.5

Analyzed by

37 Analysts

Target

$353.07

Amgen Inc target price $353.07, a slight upside of 5.54% compared to current price of $333.5. According to 37 analysts rating.

Indian Investors' Interest in Amgen Inc Stock

Investment in Amgen Inc Shares on INDmoney has grown by 98.24% in the last 30 days, indicating increased investment activity.

Time period: to

Change:98.24% versus previous 30 day period

Search interest for Amgen Inc Stock has increased by 104% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:104% versus previous 30 day period

Amgen Inc Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
8,196
7,447
8,388
8,503
9,086
8,149
9,167
9,557
9,896
8,618
Gross Profit
5,084
4,247
5,152
5,193
5,974
5,181
6,156
6,475
8,106
5,874
Operating Income
1,271
991
1,909
2,047
2,311
1,178
2,644
2,526
3,942
2,666
EBITDA
3,053
2,155
3,002
5,273
2,926
4,083
3,617
5,913
5,074
2,741
Interest Expense
821
824
808
776
747
723
708
685
653
657
Depreciation
1,380
1,399
1,400
1,396
1,397
1,387
1,341
1,307
1,132
1,116
Income Before Tax
852
-68
794
3,101
782
1,973
1,568
3,921
1,514
2,084
Income Tax Expense
85
45
48
271
155
243
136
705
181
265
Net Income
767
-113
746
2,830
627
1,730
1,432
3,216
1,333
1,819
Net Profit Margin
9.36%
-1.52%
8.89%
33.28%
6.90%
21.23%
15.62%
33.65%
13.47%
21.11%

Amgen Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
22,991
22,849
23,747
23,362
25,424
25,979
26,323
28,190
33,424
36,741
Gross Profit
18,829
18,780
19,646
19,006
19,265
19,525
19,917
19,739
20,566
26,012
Operating Income
9,794
9,973
10,263
9,674
9,139
7,639
9,566
7,897
7,258
10,676
EBITDA
12,528
12,856
12,883
12,633
12,996
11,296
12,169
7,897
13,356
15,843
Interest Expense
1,260
1,304
1,392
1,289
1,262
1,197
1,406
2,875
3,155
2,755
Depreciation
-
1,955
1,946
2,206
3,601
3,398
3,417
3,602
5,592
5,167
Income Before Tax
9,163
9,597
9,545
9,138
8,133
6,701
7,346
7,855
4,609
8,976
Income Tax Expense
1,441
7,618
1,151
1,296
869
808
794
1,138
519
1,265
Net Income
7,722
1,979
8,394
7,842
7,264
5,893
6,552
6,717
4,090
7,711
Net Profit Margin
33.59%
8.66%
35.35%
33.57%
28.57%
22.68%
24.89%
23.83%
12.24%
20.99%

Amgen Inc Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-113
746
2,830
627
1,730
1,432
3,216
1,333
1,819
Operating Cash Flow
689
2,459
3,571
4,771
1,391
2,280
4,684
1,603
2,189
Investing Cash Flow
-217
-217
-210
-402
-447
-389
-414
-693
-716
Financing Cash Flow
-1,708
-2,649
-3,651
-1,407
-4,107
-2,673
-2,853
-1,226
1,436
Change in Cash
-1,236
-407
-290
2,962
-3,163
-782
1,417
-316
2,909

Amgen Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
1,979
8,394
7,842
7,264
5,893
6,552
6,717
4,090
7,711
Operating Cash Flow
11,177
11,296
9,150
10,497
9,261
9,721
8,471
11,490
9,958
Investing Cash Flow
-4,024
14,339
5,709
-5,401
733
-6,044
-26,204
-1,046
-1,943
Financing Cash Flow
-6,594
-22,490
-15,767
-4,867
-8,271
-4,037
21,048
-9,415
-10,859
Change in Cash
559
3,145
-908
229
1,723
-360
3,315
1,029
-2,844

Mutual Funds that own Amgen Inc Stock

Check out the Mutual Funds with significant holdings in Amgen Inc.

Global Institutional Holdings in Amgen Inc

Funds
Holdings
Capital Research Global Investors
0.86%
FMR Inc
0.67%
Geode Capital Management, LLC
2.65%
NORGES BANK
1.23%
Amvescap Plc.
0.89%

Amgen Inc News & Key Events

  • img

    Today's Timeline - 10 May

    Mon, 04:39 AM

    -

    Amgen's Phase 1b STREAM-SCLC study initiated under FDA's real-time trials initiative, aiming to enhance oncology drug development.

Insights on Amgen Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Amgen Inc. has shown strong financial performance in its most recent quarters. The company's net profit has increased for the last two quarters, rising from $1.33 billion to $1.81 billion. This reflects an average increase of 26.7% per quarter.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, AMGN stock has moved up by 1.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, ASTRAZENECA PLC has given 172.5% return, outperforming this stock by 148.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, ASTRAZENECA PLC has given 146.9% return, outperforming this stock by 102.5%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Amgen Inc. has experienced a decline in revenue over the last two quarters. Specifically, their revenue decreased from $9.89 billion to $8.61 billion, averaging a drop of 12.9% per quarter.

About Amgen Inc

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is he
OrganisationAmgen Inc
HeadquartersOne Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799
IndustryDrug Manufacturers - General
CEOMr. Robert A. Bradway
E-voting on sharesClick here to vote

Key Management of Amgen Inc

Name

Title

Mr. Scott Skellenger

Senior VP & Chief Information Officer

Casey Capparelli

Executive Director of Investor Relations

Mr. Robert A. Bradway

Chairman & CEO

Mr. Peter H. Griffith

Executive VP & CFO

Dr. David M. Reese M.D.

Executive VP & CTO

Mr. Murdo Gordon

Executive Vice President of Global Commercial Operations

Dr. James E. Bradner M.D.

Executive Vice President of Research & Development

Mr. Esteban Santos

Executive Vice President of Operations

Mr. Matthew C. Busch

Chief Accounting Officer & VP of Finance

Mr. Howard Y. Chang M.D., Ph.D.

Senior VP of Global Research & Chief Scientific Officer

FAQs

What is Amgen Inc share price today?

Amgen Inc share price today is $333.5 as on . Amgen Inc share today touched a day high of $338 and a low of $330.06.

What is the 52 week high and 52 week low for Amgen Inc share?

Amgen Inc share touched a 52 week high of $391.29 on and a 52 week low of $261.43 on . Amgen Inc stock price today i.e. is trending at $333.5,which is 14.77% down from its 52 week high and 27.57% up from its 52 week low.

What is Amgen Inc's market capitalisation today?

Amgen Inc market capitalisation is $0.18T as on .

How to invest in Amgen Inc Stock (AMGN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Amgen Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Amgen Inc Shares that will get you 0.0045 shares as per Amgen Inc share price of $333.5 per share as on May 13, 2026 at 10:38 pm IST.

What is the minimum amount required to buy Amgen Inc Stock (AMGN) from India?

Indian investors can start investing in Amgen Inc (AMGN) shares with as little as ₹95.705 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.05 in Amgen Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Amgen Inc share’s latest price of $333.5 as on May 13, 2026 at 10:38 pm IST, you will get 0.0300 shares of Amgen Inc. Learn more about fractional shares .

What are the returns that Amgen Inc has given to Indian investors in the last 5 years?

Amgen Inc stock has given 33.41% share price returns and 29.72% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?